GRAY MARY ANN 4

What Happened
Mary Ann Gray, a director of RAPT Therapeutics, received an award of 4,956 restricted stock units (RSUs) on January 30, 2026. The reported acquisition price is $0.00 (award/grant, code A), so no cash was paid. The RSUs represent a contingent right to one share of common stock per RSU and fully vest on the first anniversary of the grant (Jan 30, 2027).

Key Details

• Transaction date: 2026-01-30; Form 4 filed: 2026-02-02 (timely filing).
• Transaction type/code: Award/Grant (A). Price reported: $0.00; aggregate cash value shown as $0.
• Number of RSUs granted: 4,956.
• Vesting: Fully vests one year after grant date (per footnote).
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote: Grant is the annual director RSU award under the issuer’s non-employee director compensation policy; each RSU converts to one share upon vesting.

Context: This is a routine director compensation award rather than an open-market purchase or sale. Such grants are common as part of board compensation and do not, by themselves, indicate a buy or sell signal.